## Core Concept
The question describes a clinical scenario suggestive of **Homocystinuria**, a genetic disorder characterized by elevated levels of homocysteine in the urine and blood. This condition is associated with **subluxation of the lens (ectopia lentis)**, mental retardation, and an increased risk of thromboembolic events. The disorder is caused by a deficiency in **cystathionine beta-synthase**, an enzyme crucial for the metabolism of the amino acid methionine.

## Why the Correct Answer is Right
The correct answer involves the use of **Pyridoxine (Vitamin B6)**. Pyridoxine is a cofactor for the enzyme cystathionine beta-synthase. Some patients with homocystinuria respond to large doses of pyridoxine, which can reduce homocysteine levels and mitigate some of the clinical manifestations of the disease, such as thromboembolic events and possibly some degree of mental retardation or developmental delay. The responsiveness to pyridoxine is not universal and depends on the specific mutation causing the enzyme deficiency.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because while **Folate** and **Vitamin B12** are involved in the broader metabolic pathway of homocysteine (through the methionine cycle), they are not the primary treatment for homocystinuria caused by cystathionine beta-synthase deficiency.
- **Option B:** This option is incorrect as there is no common treatment or association with this condition described by this choice.
- **Option D:** This option is incorrect because, although **Betaine** can reduce homocysteine levels by donating a methyl group to homocysteine to form methionine, it is not the first-line treatment for homocystinuria due to cystathionine beta-synthase deficiency.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that patients with homocystinuria may exhibit **marfanoid habitus** (tall stature, long limbs, and finger abnormalities) and are at increased risk of **thromboembolic events**. Early diagnosis and treatment, including pyridoxine supplementation in responsive patients, dietary restriction of methionine, and supplementation with other vitamins, can significantly impact the management and outcome of the disease.

## Correct Answer Line
**Correct Answer: C. Pyridoxine.**